NHS England has immediately paused new prescriptions of testosterone or oestrogen to under-18s who question their gender. Finally catching up to the Cass Review in 2024, nearly two years ago…
National Medical Director for Specialised Services at NHS England Professor James Palmer said:
“The NHS has exercised extreme caution when considering starting young people on this treatment. [The Cass Review] had been exceptionally thorough and complex [and] established that the available evidence does not support the continued use of masculinising or feminising hormones…”
A 90-day public consultation (yes, another ‘consultation’) on the new policy and review findings starts today. Some trans activist groups are already calling the decision ‘discriminatory’. Even as the NHS warns it is “not clear” if handing 16-year olds these drugs is at all effective…
Home Secretary Shabana Mahmood introduced her speech on migration reforms at the IPPR:
“There’s no denying we meet at a difficult time for my party.”